Hospital discharges for adnexa and eye diseases in the Netherlands have significantly declined from 2013 to 2021, evidenced by a CAGR of -10.04% in 2013 and reaching -11.65% in 2021. A notable uptick occurred in 2022 with a 37.01% increase, followed by moderate forecasts through 2028, where the CAGR is projected at -0.46%. The average annual forecasted decrease (CAGR) for the next five years stands at -0.46%, with an overall decline rate of -2.29%.
Future Trends to Watch: Monitoring the impact of technological advancements in treatments, the aging population, and accessibility to healthcare services are crucial for understanding future hospital discharge trends for adnexa and eye diseases in the Netherlands.
